*

Penny Stock DD

Penny Stocks

I hope some of you took the advantage and listened to me on my Alert on BRZM. You would have made a huge gain already. How high will it continue to go? That is the question.I personally think in my opinion that they will let it run for awhile and then rip back the stock. That is when you want to be out of it if they do a reverse split on this thing. I cannot see them doing anything else but rip it back. I think they will do a name change, go through getting a new symbol for trading because remember their business use to be in mining. Now they are in the business of B2B. In my years of market experience, this is how I see it going down.

cheers

DRD

Regards,

Don

I cannot hold back any longer as this has been one of my favorite areas of research. Be patient with this one as we are into new territory and somewhat controversial by nature.I am trying to get you in on the ground floor and that is why I decided to put this out tonight. Keep an eye on ISCO: OTC BB.

Regards,

Don

PanGenex Corp. (OTC: PGCX.PK)

PanGenex is a publicly traded corporation (OTC: PGCX.PK) and pursues business opportunities in the $70 billion dollar nutraceutical and dietary supplement industry. With a focus specifically on the cardiovascular health segment, PanGenex develops and markets sector leading, patented or patent pending, condition specific nutraceuticals and topical over-the-counter (OTC) drugs and personal care products. Each product is scientifically formulated to address specific health conditions throughout the population. Many of our products contain the purest grade of nutraceutical components available anywhere without a prescription. PanGenex markets products through healthcare practitioners throughout the U.S., fine retail establishments and the internet on websites such as www.HeartHealthyWorld.com and www.Calgenex.com.

PanGenex and the leading cardiologists in the country have developed proprietary, trademarked and patent-pending nutraceutical products targeted at cardiovascular health and wellness and specifically:

  • Soft Tissue Calcification (Hard Plaque)
  • Cholesterol Balancing (Soft Plaque)
  • Chronic Skin Conditions

(Read the Rest of the Article…)

Regards,

Don

A DRD Stock Pick :SQNM

March 24, 2010

Sequenom (SQNM) leads the list of top gainers so far today and is now at $6.55, up $1.11 (20%) . The stock was upgraded at Lazard Capital this morning to Buy from Hold. Over the last 52 weeks the stock has ranged from a low of $2.55 to a high of $8.65. Sequenom stock has been showing support around $4.86 and resistance in the $6.02 range. Technical indicators for the stock are bearish and S&P does not currently have a STARS rating for SQNM. If you are looking for a hedged play on SQNM the stock seems like it could be a candidate for a May out-of-the-money bull-put credit spread below the 5 range

Regards,

Don

More on this topic (What's this?)
Sequenom (SQNM) Jumps 22% on Analyst Upgrade
Stock To Watch – Sequenom
Read more on Sequenom, Drdgold at Wikinvest

Stocks Driven By Analyst Comments

Shares of Saks Inc. (SKS) have shown a strong upward move in morning trading, with the luxury retailer currently posting a 6.6 percent gain. At its high for the session, Saks was at its best intraday level in eighteen months.

The gain by Saks comes after J.P. Morgan upgraded its rating on the company’s stock to Overweight from Neutral. J.P. Morgan noted that Saks has reported same-store sales growth for three straight months due in part to a resumption of luxury spending.

American Semiconductor (AMSC) is also turning in a strong performance after Jefferies raised its rating on the stock to Buy from Hold, citing its attractive price level. Shares of American Semiconductor are currently up 6.8 percent, bouncing off an eight-month closing low.

(Read the Rest of the Article…)

Regards,

Don

Performance Optimization WordPress Plugins by W3 EDGE